Clinical Trial Update: A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder

View source ↗

Summary

A longitudinal observational cohort study is being conducted to evaluate NSI-189 in outpatients with major depressive disorder. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NSI-189 (NSI-189)

Snippet

Sponsor: Neuralstem Inc. | Conditions: Major Depressive Disorder | Status: UNKNOWN